- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04533516
Additional Manual Therapy Over Inspiratory Muscle Training in COPD
Effectiveness of 12-Weeks Inspiratory Muscle Training With Manual Therapy in Patients With COPD: Randomized Controlled Study
The benefits of inspiratory muscle training(IMT) in patients with chronic obstructive pulmonary disease(COPD) were reported.But in severe COPD patients, benefit from IMT may be limited.There is need for further research in new and complementary modalities to improve IMT efficiency in severe COPD patients.Manual therapy(MT) additional over IMT may be such a new approach that has not yet been investigated in COPD.
Aims: To investigate effects of MT additional over IMT on functional capacity,respiratory muscle strength,pulmonary function,dyspnea, fatigue and quality of life in severe COPD patients.
Methods: It was a prospective single-blind randomized trial. 40 patients with COPD in Global Initiative for Chronic Obstructive Lung Disease(GOLD) stage III-IV were included. Patients were randomly assigned to receive either MT additional over IMT at 40% of maximal inspiratory pressure(MIP)(n= 20) or only IMT(n= 20) for 12 weeks. MT group received MT during 12 weeks for 40 minutes additional to IMT. Pulmonary function using spirometry, respiratory muscle strength using mouth pressure device, functional capacity using six minute walk test, dyspnea using Modified Medical Research Council(MMRC) dyspnea scale, fatigue using fatigue severity scale and quality of life using St. George's Respiratory Questionnaire(SGRQ) were evaluated.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
İstanbul, Turkey, 34010
- Istinye University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of chronic obstructive pulmonary disease
- Being clinically stable
- Having FEV1/FVC ratio of ≤ 50% of the predicted value after bronchodilator drugs.
Exclusion Criteria:
- Having an acute bronchitis,
- Having a pneumonia,
- Having an exacerbation of COPD,
- Having thoracic spinal scoliosis,
- Having substantial chest wall deformity, or acute rib or vertebral fracture.
- Unable to perform the pulmonary function test because of cognitive or physical impairments.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Manual Therapy additional over Inspiratory muscle training
Participants receive manual therapy protocol session three times a week for 12 weeks.
The manual therapy protocol session lasts 30 minutes and included of the following manual therapy techniques: suboccipital decompression, gliding of the cervical vertebral articulations in the anterior/posterior direction, myofascial release of sternocleidomastoid and trapezius muscles, gliding of sternoclavicular joint in the anterior/posterior direction, myofascial release of intercostal muscles and paravertebral muscles, diaphragmatic release, rib raising, mobilization of scapulothoracic joint, and gliding of the thoracic vertebral articulations in the anterior/posterior direction.
And all participants receive inspiratory muscle training.
|
Manual therapy technics
Inspiratory Muscle Training
|
Active Comparator: Inspiratory Muscle Training
Participants receive only inspiratory muscle training by using Threshold Inspiratory Muscle Training device.
Training load is 40% of the measured maximum inspiratory pressure, weekly.
Participants receive inspiratory muscle training session for 30 min-per day, 7 days per week, for 12 weeks.
|
Inspiratory Muscle Training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pulmonary Function Test
Time Frame: 12 weeks
|
Before the pulmonary function test, all subjects rested to avoid fatigue.
The lung function test including forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and vital capacity (VC) was performed in a seated position using a portable spirometer according to the American Thoracic Society guidelines.
|
12 weeks
|
respiratory muscle strength
Time Frame: 12 weeks
|
For respiratory muscle strength, maximal inspiratory pressure (MIP), and maximal expiratory pressure (MEP) were evaluated using an electronic pressure transducer.
MIP was measured at residual volume, and MEP was measured from total lung capacity.
|
12 weeks
|
6 minute walk test
Time Frame: 12 weeks
|
6 minute walk test (6MWT) was applied to measure exercise capacity.
The patient's heart rate, breathing frequency, and oxygen saturation were monitored with the pulse oximeter, and the values were recorded before and after the test.
The distance was expressed both as metres.
|
12 weeks
|
Dyspnea perception
Time Frame: 12 weeks
|
Dyspnea perception was assessed using the modified Medical Research Council (MMRC) dyspnea scale, Levels of dyspnea are graded 0 (absence of dyspnea during strenuous exercise), to 4 (dyspnea during daily activities).
|
12 weeks
|
Fatigue perception
Time Frame: 12 weeks
|
Fatigue perception was assessed with Turkish version of Fatigue Severity Scale.
A high score indicates increased fatigue intensity and the maximum score of the scale is 63.
|
12 weeks
|
St.George Respiratory Questionnaire
Time Frame: 12 weeks
|
Quality of life was measured using the Turkish version of St.George Respiratory Questionnaire (SGRQ).
It is a specific quality of life questionnaire for respiratory diseases.
SGRQ consists of three subscale and 50 items; symptoms (8 items), activities (16 items), effects of the disease (26 items).
Each subscale is scored ranging from 0 to 100 points.
High scores indicate that worsened the quality of life.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Lung Diseases
- Neurologic Manifestations
- Musculoskeletal Diseases
- Muscular Diseases
- Neuromuscular Manifestations
- Lung Diseases, Obstructive
- Pulmonary Disease, Chronic Obstructive
- Respiratory Aspiration
- Muscle Weakness
Other Study ID Numbers
- manual therapy in COPD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Weakness
-
St. Luke's-Roosevelt Hospital CenterCompletedFall Risk | Quadriceps Muscle Weakness | Adductor Muscle WeaknessUnited States
-
Association Pro-arteActive, not recruitingWeakness, Muscle | AmyotrophiaFrance
-
University of Central ArkansasCompletedPelvic Floor Muscle WeaknessUnited States
-
Ludwig Boltzmann Institute of Electrical Stimulation...Medical University of Vienna; European Union; Comenius University; Ministry of...CompletedMuscle Weakness Condition | Therapy EffectAustria, Slovakia
-
Rutgers, The State University of New JerseyRecruitingPhysical Disability | Muscle Atrophy or Weakness | Muscle Loss | Physical Inactivity | Delirium in Old Age | Hospital Acquired Condition | Weakness, MuscleUnited States
-
University of MilanCompleted
-
University of Central FloridaCompletedMuscle Weakness | Muscle Atrophy | Muscle Loss | Weakness, Muscle | Injury, KneeUnited States
-
University of Texas Southwestern Medical CenterTerminatedMuscle Cramp | Statin Adverse Reaction | Weakness, Muscle | AcheUnited States
-
Riphah International UniversityCompletedMuscle Weakness ConditionPakistan
-
Damanhour UniversityCompletedNeuromuscular Electrical Stimulation | ICU Acquired Muscle WeaknessEgypt
Clinical Trials on Manual therapy technics
-
Hacettepe UniversityCompletedChronic Low Back PainTurkey
-
Hopital FochRecruiting
-
Alexander AchalandabasoCompletedChronic Pain | Neck PainSpain
-
Universidad de ZaragozaCompletedPlagiocephaly | Plagiocephaly, Nonsynostotic | Plagiocephaly, PositionalSpain
-
Josue Fernandez CarneroUniversidad Autonoma de MadridCompletedCervicalgia | Neck Pains | Posterior Cervical Pains | Posterior Neck Pain
-
Hacettepe UniversityCompletedHealth Young IndividualsTurkey
-
Cesar A Hincapié, DC PhDEpidemiology, Biostatistics and Prevention Institute, University of ZurichCompletedBack Pain | Back Pain, Low | Back DisorderSwitzerland
-
University of PalermoCompleted
-
Universidad de ZaragozaCompletedEndodontically Treated Teeth | Root Canal TherapySpain